ME01858B - Jedinjenje triazolopiridina i njegovo dejstvo kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina - Google Patents

Jedinjenje triazolopiridina i njegovo dejstvo kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina

Info

Publication number
ME01858B
ME01858B MEP-2014-82A MEP8214A ME01858B ME 01858 B ME01858 B ME 01858B ME P8214 A MEP8214 A ME P8214A ME 01858 B ME01858 B ME 01858B
Authority
ME
Montenegro
Prior art keywords
eritropoetin
manufacturer
action
prolyl hydroxylase
hydroxylase inhibitor
Prior art date
Application number
MEP-2014-82A
Other languages
English (en)
Inventor
Ikuo Mitani
Yosuke Ogoshi
Takuya Matsui
Masahiro Yokota
Masakazu Terashita
Dai Motoda
Kazuhito Ueyama
Takahiro Hotta
Takashi Ito
Hiroyuki Abe
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of ME01858B publication Critical patent/ME01858B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
MEP-2014-82A 2009-07-17 2010-07-16 Jedinjenje triazolopiridina i njegovo dejstvo kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina ME01858B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009169565 2009-07-17
US27312709P 2009-07-30 2009-07-30
PCT/JP2010/062037 WO2011007856A1 (ja) 2009-07-17 2010-07-16 トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用
EP10799914.6A EP2455381B9 (en) 2009-07-17 2010-07-16 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer

Publications (1)

Publication Number Publication Date
ME01858B true ME01858B (me) 2014-12-20

Family

ID=43449466

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2014-82A ME01858B (me) 2009-07-17 2010-07-16 Jedinjenje triazolopiridina i njegovo dejstvo kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina

Country Status (28)

Country Link
US (3) US8283465B2 (me)
EP (3) EP2746282A1 (me)
JP (9) JP5021797B2 (me)
KR (5) KR101850661B1 (me)
CN (1) CN102471337B (me)
AR (1) AR077417A1 (me)
AU (1) AU2010271732B2 (me)
BR (1) BR112012001157A2 (me)
CA (1) CA2768505C (me)
CO (1) CO6430426A2 (me)
DK (1) DK2455381T5 (me)
ES (1) ES2477968T3 (me)
HR (1) HRP20140705T1 (me)
IL (1) IL217541A (me)
ME (1) ME01858B (me)
MX (1) MX2012000766A (me)
MY (1) MY160814A (me)
NZ (1) NZ598242A (me)
PE (1) PE20120629A1 (me)
PL (1) PL2455381T3 (me)
PT (1) PT2455381E (me)
RS (1) RS53499B1 (me)
RU (1) RU2538963C2 (me)
SG (1) SG178049A1 (me)
SI (1) SI2455381T1 (me)
SM (1) SMT201500122B (me)
TW (1) TWI485150B (me)
WO (1) WO2011007856A1 (me)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2455381T1 (sl) * 2009-07-17 2014-08-29 Japan Tobacco Inc. Triazolopiridinova spojina in njeno delovanje kot zaviralec prolil-hidroksilaze in induktor produkcije eritropoietina
JP2011168582A (ja) * 2010-01-21 2011-09-01 Ishihara Sangyo Kaisha Ltd トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
WO2012065297A1 (en) * 2010-11-16 2012-05-24 Impact Therapeutics, Inc. 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
US10004718B2 (en) 2012-11-26 2018-06-26 Tohoku University Erythropoietin expression promoter
WO2014102818A1 (en) 2012-12-24 2014-07-03 Cadila Healthcare Limited Novel quinolone derivatives
SG10201910773VA (en) 2013-06-13 2020-01-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
RU2534804C1 (ru) * 2013-08-05 2014-12-10 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") ЗАМЕЩЕННЫЕ [1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ, ПРОЯВЛЯЮЩИЕ СВОЙСТВА АНТАГОНИСТОВ АДЕНОЗИНОВЫХ А2А РЕЦЕПТОРОВ, И ИХ ПРИМЕНЕНИЕ
EP3363800A1 (en) * 2013-10-03 2018-08-22 Kura Oncology, Inc. Heterocyclic inhibitors of erk and methods of use
JP6506390B2 (ja) 2014-09-02 2019-04-24 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． キノリノン系化合物及びその薬物への使用
JP2018039733A (ja) * 2014-12-22 2018-03-15 株式会社富士薬品 新規複素環誘導体
GB201504565D0 (en) * 2015-03-18 2015-05-06 Takeda Pharmaceutical Novel compounds
CN106146395B (zh) * 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3-羟基吡啶化合物、其制备方法及其制药用途
US20180243271A1 (en) * 2015-05-28 2018-08-30 Japan Tobacco Inc. Method for Treating or Preventing Diabetic Nephropathy
MX2019006083A (es) * 2016-11-25 2019-07-10 Japan Tobacco Inc Metodo para la produccion de compuesto de triazolopiridina.
CA3062972C (en) 2017-05-09 2021-09-14 Kind Pharmaceutical Indolizine derivatives and their application in medicine
AR113270A1 (es) * 2017-10-04 2020-03-11 Japan Tobacco Inc Compuesto de heteroarilo con contenido de nitrógeno y su uso farmacéutico
CN107739378A (zh) * 2017-11-14 2018-02-27 杭州安道药业有限公司 吲哚嗪衍生物及其在医药上的应用
JP7458987B2 (ja) * 2018-09-13 2024-04-01 キッセイ薬品工業株式会社 イミダゾピリジノン化合物
CN110105355B (zh) * 2019-05-24 2021-09-21 烟台大学 一种1,2,3-三唑-[1,5-a]并喹啉类化合物的制备方法
CA3169000A1 (en) * 2020-03-11 2021-09-16 Hideki Takeuchi Crystal of imidazopyridinone compound or salt thereof
JP7504822B2 (ja) * 2020-03-12 2024-06-24 キッセイ薬品工業株式会社 イミダゾピリジノン化合物を含む医薬組成物
WO2021216530A1 (en) 2020-04-20 2021-10-28 Akebia Therapeutics, Inc. Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer
WO2022150623A1 (en) 2021-01-08 2022-07-14 Akebia Therapeutics, Inc. Compounds and composition for the treatment of anemia
CN113387948B (zh) * 2021-02-06 2022-06-10 成都诺和晟泰生物科技有限公司 一种稠环杂芳基衍生物及其药物组合物和治疗方法及用途
WO2022195532A1 (en) 2021-03-19 2022-09-22 Zydus Lifesciences Ltd. Treatment for sickle cell anaemia
CN117999069A (zh) 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物
CN113582843A (zh) * 2021-09-09 2021-11-02 无锡捷化医药科技有限公司 一种5-氯-2-氟-3-羟基苯甲酸乙酯的制备方法
CN116496269B (zh) * 2021-12-02 2025-02-28 苏中药业集团股份有限公司 一种脯氨酰羟化酶抑制剂及其用途
CN114031619A (zh) * 2021-12-17 2022-02-11 山东汇海医药化工有限公司 一种图卡替尼中间体的制备方法
CN117327066A (zh) * 2022-06-30 2024-01-02 上海济煜医药科技有限公司 一种新多晶型、其制备方法及其用于制备药物的用途
TW202412778A (zh) * 2022-09-19 2024-04-01 大陸商蘇中藥業集團股份有限公司 一種脯氨醯羥化酶抑制劑及其用途
CN121443606A (zh) * 2023-06-02 2026-01-30 苏中药业集团股份有限公司 一种脯氨酰羟化酶抑制剂及其用途
TW202506675A (zh) * 2023-08-08 2025-02-16 美商富曼西公司 用於防治和對抗無脊椎有害生物的連接的雙環化合物
AU2024366956A1 (en) 2023-10-24 2026-04-09 Kind Pharmaceutical Long-acting oral pharmaceutical comprising hypoxia-inducible factor prolyl hydroxylase inhibitor and use thereof
CN117486878A (zh) * 2023-10-27 2024-02-02 扬州市普林斯医药科技有限公司 一种恩那司他的制备方法
WO2025137158A1 (en) * 2023-12-19 2025-06-26 Akebia Therapeutics, Inc. Derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate as phd inhibitor compounds, compositions, and methods of use
CN119818492B (zh) * 2024-02-05 2026-01-30 深圳信立泰药业股份有限公司 化合物在制备治疗非髓系恶性肿瘤患者的贫血药物中的应用
CN119700755B (zh) * 2024-02-05 2026-01-30 深圳信立泰药业股份有限公司 化合物在制备预防和/或治疗高原病的药物中的应用
CN119039291A (zh) * 2024-09-09 2024-11-29 南京药坦生物科技有限公司 一种恩那度司他中间体及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746287A1 (de) 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US6355653B1 (en) * 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
US6514989B1 (en) * 2001-07-20 2003-02-04 Hoffmann-La Roche Inc. Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
AU2002347055B2 (en) * 2001-10-08 2006-10-12 F. Hoffmann-La Roche Ag Substituted Triazolopyridine Compounds
WO2005014533A2 (en) 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
AU2005268893B2 (en) * 2004-08-05 2011-10-13 F. Hoffmann-La Roche Ag Indole, indazole or indoline derivatives
FR2889383A1 (fr) * 2005-08-01 2007-02-02 France Telecom Procede et dispositif de detection pour systeme mimo, systeme mimo, programme et support d'information
AR059733A1 (es) 2006-03-07 2008-04-23 Smithkline Beecham Corp Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion
WO2007136990A2 (en) * 2006-05-16 2007-11-29 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
JO2934B1 (en) * 2006-06-23 2015-09-15 سميث كلاين بيتشام كوربوريشن Prolyl hydroxylase inhibitors
BRPI0713350B1 (pt) * 2006-06-26 2022-04-12 Akebia Therapeutics Inc Composto, e, composição
US20100035756A1 (en) 2006-07-12 2010-02-11 Syngenta Limited Triazolophyridine derivatives as herbicides
TW200845991A (en) * 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: hydroxylase inhibitors
EP2142509B1 (en) * 2007-04-18 2013-12-04 Amgen, Inc Quinolones and azaquinolones that inhibit prolyl hydroxylase
US8097620B2 (en) 2007-05-04 2012-01-17 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
JP5408434B2 (ja) 2007-07-03 2014-02-05 アステラス製薬株式会社 アミド化合物
US20100305133A1 (en) * 2007-11-30 2010-12-02 Smithkline Beecham Corporation Prolyl Hydroxylase Inhibitors
WO2009070644A1 (en) * 2007-11-30 2009-06-04 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
WO2009126624A1 (en) * 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolo compounds useful as dgat1 inhibitors
US20110039895A1 (en) 2008-04-30 2011-02-17 Glaxo Smith Kline LLC., a corporation Prolyl hydroxylase inhibitors
CN102112475A (zh) 2008-05-29 2011-06-29 西特里斯药业公司 作为沉默调节蛋白调节剂的咪唑并吡啶和相关的类似物
RU2544011C2 (ru) 2008-12-19 2015-03-10 Лео Фарма А/С Триазолопиридины в качестве ингибиторов фосфодиэстеразы для лечения кожных заболеваний
SI2455381T1 (sl) * 2009-07-17 2014-08-29 Japan Tobacco Inc. Triazolopiridinova spojina in njeno delovanje kot zaviralec prolil-hidroksilaze in induktor produkcije eritropoietina

Also Published As

Publication number Publication date
EP2455381A1 (en) 2012-05-23
SG178049A1 (en) 2012-03-29
KR20120051704A (ko) 2012-05-22
KR20230165366A (ko) 2023-12-05
SI2455381T1 (sl) 2014-08-29
US20130096155A1 (en) 2013-04-18
CA2768505A1 (en) 2011-01-20
RU2012105467A (ru) 2013-08-27
JP2016040321A (ja) 2016-03-24
JP2022126843A (ja) 2022-08-30
DK2455381T3 (da) 2014-07-21
US20110077267A1 (en) 2011-03-31
RU2538963C2 (ru) 2015-01-10
PL2455381T3 (pl) 2014-10-31
CO6430426A2 (es) 2012-04-30
AR077417A1 (es) 2011-08-24
US8283465B2 (en) 2012-10-09
JP2011037841A (ja) 2011-02-24
EP3594213A1 (en) 2020-01-15
KR101706803B1 (ko) 2017-02-14
US20160145254A1 (en) 2016-05-26
MX2012000766A (es) 2012-02-08
AU2010271732B2 (en) 2016-08-25
KR20260012830A (ko) 2026-01-27
EP2455381A4 (en) 2012-12-12
DK2455381T5 (en) 2015-02-09
HK1168346A1 (en) 2012-12-28
JP2020111612A (ja) 2020-07-27
JP2019019144A (ja) 2019-02-07
NZ598242A (en) 2013-09-27
BR112012001157A2 (pt) 2016-02-23
JP6434575B2 (ja) 2018-12-05
EP2455381B1 (en) 2014-05-28
JP2024091878A (ja) 2024-07-05
CA2768505C (en) 2018-06-12
MY160814A (en) 2017-03-31
CN102471337B (zh) 2014-12-10
RS53499B1 (sr) 2015-02-27
CN102471337A (zh) 2012-05-23
JP5021797B2 (ja) 2012-09-12
ES2477968T9 (es) 2014-11-13
TW201105671A (en) 2011-02-16
JP2017214404A (ja) 2017-12-07
JP2015003933A (ja) 2015-01-08
PE20120629A1 (es) 2012-05-30
EP2455381B9 (en) 2014-10-22
WO2011007856A1 (ja) 2011-01-20
IL217541A (en) 2014-07-31
PT2455381E (pt) 2014-06-24
KR101850661B1 (ko) 2018-04-19
ES2477968T3 (es) 2014-07-18
IL217541A0 (en) 2012-02-29
AU2010271732A1 (en) 2012-03-08
KR20180042443A (ko) 2018-04-25
KR20170018105A (ko) 2017-02-15
TWI485150B (zh) 2015-05-21
SMT201500122B (it) 2015-07-09
JP2012144571A (ja) 2012-08-02
HRP20140705T1 (hr) 2014-09-12
EP2746282A1 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
ME01858B (me) Jedinjenje triazolopiridina i njegovo dejstvo kao inhibitora prolil hidroksilaze i induktora proizvodnje eritropoetina
CY2020024I2 (el) Αναστολεiς βητα-λακταμασων
DK2496236T3 (da) Prolylhydroxylasehæmmere
DK2294066T3 (da) Benzoimidazoler som prolylhydroxylaseinhibitorer
EP2305306A4 (en) NEURO INVASION INHIBITOR
BRPI0910450A2 (pt) limpador robótico
DK2246336T3 (da) Fibroseinhibitor
BRPI0918564A2 (pt) inibidores
EP2326178A4 (en) INHIBITORS OF PROLYL-HYDROXYLASE
EP2273879A4 (en) PROLYLHYDROXYLASEHEMMER
DK2639229T3 (da) Thiazolderivat og anvendelse deraf som VAP-1-hæmmer
EP2326179A4 (en) PROLYLHYDROXYLASEHEMMER
EP2306828A4 (en) INHIBITORS OF PROLYL HYDROXYLASES
DK2331548T3 (da) Proteasehæmmere
ATE522533T1 (de) Pyrazolopyrimidinonkinaseinhibitor
BRPI0919073A2 (pt) inibidores de protease
SI2496236T1 (sl) Prolilhidroksilazni inhibitorji
FI20085647A0 (fi) Manipulaattori
FI20080062A0 (fi) Työkalu